Conduction Disorders Before TAVR: What Is Their Impact?

Transcatheter aortic valve replacement (TAVR) has become an established treatment for severe aortic stenosis and is now performed in increasingly lower-risk populations.

Despite the use of high implant strategies, the need for permanent pacemaker implantation (PPI) remains a persistent challenge, particularly in patients with right bundle branch block (RBBB) and, to a lesser extent, in those with first-degree AV block (1st-degree AVB) or left bundle branch block (LBBB).

While PPI is considered a low-risk procedure, it is associated with longer hospital stays, increased hospital and follow-up costs, generator replacement needs, and a higher risk of endocarditis, tricuspid regurgitation, or other complications.

Researchers analyzed a cohort of 1069 patients who underwent TAVR. Of these, 825 (77.2%) had a preprocedural PR interval <240 ms, 44 (4.1%) had a PR interval >240 ms, 93 (8.7%) had LBBB, and 107 (10%) had RBBB.

The primary endpoint (PEP) was high-grade AV block (HAVB) at 30 days, defined as the presence of two non-conducted P waves in sinus rhythm or bradycardia <50 bpm in patients with atrial fibrillation or flutter.

Patients with conduction disorders were older and predominantly male, while women were more common in the group without conduction disturbances. Comorbidities were similar across groups, although patients with a PR interval >240 ms had a higher prevalence of myocardial revascularization surgery (MRS) and dialysis. Patients with LBBB experienced a higher incidence of diabetes and atrial fibrillation or flutter, and those with RBBB had a higher rate of prior MRS compared to the control group.

Read also: Statins and Small Abdominal Aortic Aneurysms: Unexpected Aid?

The STS mortality score was 5%. Ejection fraction averaged 60%, except in the LBBB group, where it was significantly lower (50%). The average aortic valve area was 0.8 cm². The most commonly used approach was the transfemoral access, and the most frequently implanted valve was the balloon-expandable valve (92%).

The PEP was significantly higher in patients with RBBB compared to those without conduction disorders (17.8% vs. 2.2%; p < 0.001). In the PR >240 ms and LBBB groups, the PEP was also higher, though without statistical significance (4.5% vs. 2.2%; p=0.31 and 5.4% vs. 2.2%; p=0.6, respectively).

The need for PPI was significantly higher in the RBBB and LBBB groups compared to the control group (39.2% vs. 6.1%; p <0.001 and 11.8% vs. 6.1%; p=0.03, respectively). In contrast, for patients with a PR interval >240 ms, the rate was similar to that for the control group (9.1% vs. 6.1%; p=0.42). Most HAVB episodes in the control group, as well as in the PR interval >240 ms and LBBB groups, occurred after 24 hours.

Read also: Coronary Events Following TAVI: A Registry.

Thirty-day mortality was higher in the RBBB group compared to the control group (2.8% vs. 0.5%; p=0.009), although there were no significant differences in one-year mortality among the four groups.

RBBB emerged as a predictor of high-grade AV block.

Conclusion

Despite no immediate ECG abnormalities following TAVR, 17.8% of patients with RBBB developed high-grade AV block, mostly within the first 24 hours. In contrast, its incidence was relatively low in patients with PR interval >240 ms or LBBB. Early discharge with outpatient ECG monitoring could be an appropriate strategy for these patients.

Original Title: Incidence and Predictors of High-Grade AV Block in Patients With Initially Unchanged Electrocardiogram After TAVR. 

Reference: Mohamed Elhadi, et al. JSCAI https://doi.org/10.1016/j.jscai.2025.103666. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Carlos Fava
Dr. Carlos Fava
Member of the Editorial Board of solaci.org

More articles by this author

Hemodynamic Outcomes of Edge-to-Edge Repair in Degenerative and Functional Mitral Regurgitation

Transcatheter edge-to-edge mitral valve repair (M-TEER) has become an established therapeutic option for mitral valve disease. Among the available techniques, M-TEER using the MitraClip...

SAPIEN 3 TAVI Durability: Ten-Year Follow-Up in Intermediate-Risk Patients

The durability of transcatheter bioprosthetic valves used in TAVI remains one of the key unanswered questions as indications continue to expand toward patients with...

Inflammation after TAVI: An Emerging Therapeutic Target?

Conduction disturbances and the need for permanent pacemaker implantation remain common complications following TAVI, with an incidence approaching 15%. Although they have traditionally been...

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Supera vs. Eluvia at 3 Years in Severely Calcified Femoropopliteal Lesions

Severe calcification remains one of the main predictors of restenosis and the need for repeat revascularization following endovascular treatment of femoropopliteal disease. In this...

Is IVUS Always Necessary for Left Main Coronary Artery PCI?

Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery is a highly complex procedure because of the large amount of myocardium at...

Dual-Prep Registry: Atherectomy and IVL for Severe Coronary Calcification

Severe coronary calcification remains one of the most challenging scenarios in percutaneous coronary intervention (PCI). Although rotational or orbital atherectomy and intravascular lithotripsy (IVL)...